Weekly Recap

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

ByNeurologyLive® Staff

March 7th 2020

Neurology News Network for the week ending March 7, 2020.

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

ByAugusto Miravalle, MD

March 6th 2020

The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

ByNeurologyLive® Staff

January 4th 2020

Neurology News Network for the week ending January 4, 2020.

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

ByNeurologyLive® Staff

December 14th 2019

Neurology News Network for the week ending December 14, 2019.

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

ByNeurologyLive® Staff

November 16th 2019

Neurology News Network for the week ending November 16, 2019.

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

ByNeurologyLive® Staff

October 26th 2019

Neurology News Network for the week ending October 26, 2019.

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

ByNeurologyLive® Staff

October 19th 2019

Neurology News Network for the week ending October 19, 2019.

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

ByNeurologyLive® Staff

October 5th 2019

Neurology News Network for the week ending October 5, 2019.

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

ByNeurologyLive® Staff

September 28th 2019

Neurology News Network for the week ending September 28, 2019.

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

ByNeurologyLive® Staff

September 21st 2019

Neurology News Network for the week ending September 21, 2019.

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

ByNeurologyLive® Staff

September 14th 2019

Neurology News Network for the week ending September 14, 2019.

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

ByNeurologyLive® Staff

September 7th 2019

Neurology News Network for the week ending September 7, 2019.

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

ByNeurologyLive® Staff

August 31st 2019

Neurology News Network for the week ending August 31, 2019.

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

ByNeurologyLive® Staff

August 24th 2019

Neurology News Network for the week ending August 24, 2019.

Impact of Caregiver Depression on Patients With Dementia, CAG Repeat Length Predicts Huntington Disease Decline, Novel Oral CBD Formulation Effective in Epilepsy

ByNeurologyLive® Staff

August 17th 2019

Neurology News Network for the week ending August 17, 2019.

Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast

ByNeurologyLive® Staff

August 10th 2019

Neurology News Network for the week ending August 10, 2019.

Tic Suppression Ability Predicts Future Symptom Outcomes, Wearable-Detected Gait Changes Predict Parkinson Disease, Early MRI Scans Predict Relapse-Onset Multiple Sclerosis

ByNeurologyLive® Staff

August 3rd 2019

Neurology News Network for the week ending August 3, 2019.

Highlights From the 2019 American Headache Society Annual Scientific Meeting

ByNeurologyLive® Staff

July 24th 2019

This week’s edition features highlights from NeurologyLive’s coverage of the American Headache Society’s annual scientific meeting.

Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy

ByNeurologyLive® Staff

July 13th 2019

Neurology News Network for the week ending July 13, 2019.

Nusinersen Shows Long-Term SMA Success, Positive Data for an Investigational DMD Therapy, Zogenix to Resubmit Fenfluramine NDA

ByNeurologyLive® Staff

July 6th 2019

Neurology News Network for the week ending July 6, 2019.

Perampanel Monotherapy Promotes Seizure Freedom, Intranasal Midazolam Rapidly Effective, Safe Alternative in Status Epilepticus, Sleep Disorders and Epilepsy

ByNeurologyLive® Staff

June 29th 2019

Neurology News Network for the week ending June 29, 2019.

Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness

ByNeurologyLive® Staff

June 22nd 2019

Neurology News Network for the week ending June 22, 2019.

ILAE MRI Recommendations, CPAP in OSA and MCI, Lemborexant Positive for Insomnia

ByNeurologyLive® Staff

June 15th 2019

Neurology News Network for the week ending June 15, 2019.

FDA Approves Galcanezumab for Episodic Cluster Headache, FDA Clears ReStore Exo-Suit for Stroke Rehabilitation, Alzheimer Disease May Be Influenced by LDL-C Levels

ByNeurologyLive® Staff

June 8th 2019

Neurology News Network for the week ending June 8, 2019.

FDA Approves Zolgensma for Spinal Muscular Atrophy, Nerivio Migra Device Granted De Novo Clearance for Migraine, Cladribine Reduces MRI Lesions Across Subgroups in ORACLE-MS Study

ByNeurologyLive® Staff

June 1st 2019

Neurology News Network for the week ending June 1, 2019.

FDA OKs Atlas Stent System, Wearables in Epilepsy Monitoring, and ASA Policy Statement on Stroke Care Systems

ByNeurologyLive® Staff

May 25th 2019

Neurology News Network for the week ending May 25, 2019.

New Guideline for Tourette Syndrome, Tic Disorders, FDA Approves sBLA for IncobotulinumtoxinA for Blepharospasm, Gaboxadol Shows Clinical Benefit in Angelman Syndrome

ByNeurologyLive® Staff

May 18th 2019

Neurology News Network for the week ending May 18, 2019.

Inebilizumab for NMOSD, New Acute Migraine Clinical Trial End Points, Eptinezumab's Pending BLA for Migraine Prevention

ByNeurologyLive® Staff

April 27th 2019

Neurology News Network for the week ending April 27, 2019.

Exome Panel Promising for Diagnosing Epilepsy, Pamrevlumab for Duchenne Muscular Dystrophy Receives Orphan Drug Designation, Riluzole NDA Accepted for ALS

ByNeurologyLive® Staff

April 20th 2019

Neurology News Network for the week of April 20, 2019.

Guidelines for Pediatric Migraine Clinical Trial Design Released, FDA Grants AMT-130 Fast Track Designation for Huntington Disease, ZX008 Receives RFL for Dravet Syndrome

ByNeurologyLive® Staff

April 13th 2019

Neurology News Network for the week of April 13, 2019.

Weekly Recap

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

Impact of Caregiver Depression on Patients With Dementia, CAG Repeat Length Predicts Huntington Disease Decline, Novel Oral CBD Formulation Effective in Epilepsy

Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast

Tic Suppression Ability Predicts Future Symptom Outcomes, Wearable-Detected Gait Changes Predict Parkinson Disease, Early MRI Scans Predict Relapse-Onset Multiple Sclerosis

Highlights From the 2019 American Headache Society Annual Scientific Meeting

Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy

Nusinersen Shows Long-Term SMA Success, Positive Data for an Investigational DMD Therapy, Zogenix to Resubmit Fenfluramine NDA

Perampanel Monotherapy Promotes Seizure Freedom, Intranasal Midazolam Rapidly Effective, Safe Alternative in Status Epilepticus, Sleep Disorders and Epilepsy

Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness

ILAE MRI Recommendations, CPAP in OSA and MCI, Lemborexant Positive for Insomnia

FDA Approves Galcanezumab for Episodic Cluster Headache, FDA Clears ReStore Exo-Suit for Stroke Rehabilitation, Alzheimer Disease May Be Influenced by LDL-C Levels

FDA Approves Zolgensma for Spinal Muscular Atrophy, Nerivio Migra Device Granted De Novo Clearance for Migraine, Cladribine Reduces MRI Lesions Across Subgroups in ORACLE-MS Study

FDA OKs Atlas Stent System, Wearables in Epilepsy Monitoring, and ASA Policy Statement on Stroke Care Systems

New Guideline for Tourette Syndrome, Tic Disorders, FDA Approves sBLA for IncobotulinumtoxinA for Blepharospasm, Gaboxadol Shows Clinical Benefit in Angelman Syndrome

Inebilizumab for NMOSD, New Acute Migraine Clinical Trial End Points, Eptinezumab's Pending BLA for Migraine Prevention

Exome Panel Promising for Diagnosing Epilepsy, Pamrevlumab for Duchenne Muscular Dystrophy Receives Orphan Drug Designation, Riluzole NDA Accepted for ALS

Guidelines for Pediatric Migraine Clinical Trial Design Released, FDA Grants AMT-130 Fast Track Designation for Huntington Disease, ZX008 Receives RFL for Dravet Syndrome

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Overviewing Promising Phase 1/2 Data of Gene Therapy ETX101 in Dravet Syndrome: Joseph Sullivan, MD

US Survey Reveals Underuse of Dravet Syndrome–Specific Antiseizure Medications in the Clinic

Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles

AES Poster Lays Insights Into EEG and MRI Biomarkers of MOGAD-Related Epilepsy

AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome